Nava Health Redefines Women’s Longevity with Precision Bioidentical Hormone Therapy Following Landmark 2025 Menopause Study
United States, 20th Jan 2026 — Nava Health, a leading integrative and functional medicine provider, is redefining the future of women’s longevity care through precision-driven hormone solutions following insights from a landmark 2025 menopause study. The study highlights the profound long-term health impact of hormonal imbalance during midlife, reinforcing the need for personalized, technology-enabled menopause care—an area where Nava Health continues to lead with innovation.
As women’s life expectancy increases, menopause is no longer viewed as a brief transition but as a pivotal phase that can shape metabolic health, cardiovascular resilience, cognitive function, bone density, and overall vitality for decades. Nava Health addresses this challenge through an advanced functional medicine ...
